Kurzius doubled his direct stake in the medical device company despite a 19% one-year stock decline, signaling confidence in COO's turnaround prospects.
Insider purchased shares through his revocable trust following a 19% stock decline over the past year, doubling his indirect holdings to 20,000 shares.
Insider doubled down after stock fell 16% over the past year, signaling confidence in the contact lens and surgical care provider's recovery prospects.
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a co...
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
What Happened? Shares of medical device company CooperCompanies (NASDAQ:COO) fell 13.9% in the afternoon session after the company reported weak second-quart...
Medical device company CooperCompanies (NASDAQ:COO) missed Wall Street’s revenue expectations in Q2 CY2026, with sales flat year on year at $1.07 billion. Th...
Cooper Companies (NASDAQ:COO) reported third-quarter fiscal 2026 revenue of $1.066 billion, up about 1% on both a reported and organic basis, as record free cash flow and earnings growth offset pressure at its CooperVision contact lens business from planned U.S. channel inventory reductions.
Non-GA
Cooper Companies (NASDAQ:COO) reported third-quarter financial results on Wednesday. The transcript from the company's third-quarter earnings call has been provided below. This transcript is brought to you by
Medical device company CooperCompanies (NASDAQ:COO) fell short of the market’s revenue expectations in Q2 CY2026, with sales flat year on year at $1.07 billi...
